The Key Cell and Gene Therapies in Rare Disorders Companies in the market include – Pfizer, Sangamo Therapeutics, Orchard Therapeutics/ SR-Tiget, Novartis, TVAX Biomedical, Aivita Biomedical, RHEACELL GmbH & Co, Capricor Therapeutics, and others. DelveInsight’s “Cell and Gene Therapies in Rare Disorders Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of […]
